MDxHealth SA (MDXH)

NASDAQ: MDXH · Real-Time Price · USD
2.360
-0.040 (-1.67%)
Dec 12, 2024, 4:00 PM EST - Market closed
-1.67%
Market Cap 111.60M
Revenue (ttm) 84.71M
Net Income (ttm) -41.95M
Shares Out 47.29M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,881
Open 2.380
Previous Close 2.400
Day's Range 2.350 - 2.390
52-Week Range 1.550 - 4.640
Beta -391,052.41
Analysts Strong Buy
Price Target 7.00 (+196.61%)
Earnings Date Nov 6, 2024

About MDXH

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient’s previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personaliz... [Read more]

Sector Healthcare
IPO Date Nov 4, 2021
Employees 300
Stock Exchange NASDAQ
Ticker Symbol MDXH
Full Company Profile

Financial Performance

In 2023, MDxHealth's revenue was $70.19 million, an increase of 89.43% compared to the previous year's $37.05 million. Losses were -$43.10 million, -2.14% less than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for MDXH stock is "Strong Buy." The 12-month stock price forecast is $7.0, which is an increase of 196.61% from the latest price.

Price Target
$7.0
(196.61% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

MDxHealth to Participate in Piper Sandler Healthcare Conference

MDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnos...

17 days ago - GlobeNewsWire

MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript

MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Michael K. McGarrity - Chief Executive Officer and Director Ron Kalfus - Chief Financial O...

4 weeks ago - Seeking Alpha

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

Tissue-based test volumes increase by 36%, liquid-based test volumes by 24% Company raises 2024 revenue guidance to $87-89 million, representing 25% growth Pro-forma cash of $53.5 million Conference c...

5 weeks ago - GlobeNewsWire

MDxHealth Announces Pricing of Offering of Ordinary Shares

MDxHealth Announces Pricing of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company“), a commerc...

2 months ago - GlobeNewsWire

MDxHealth Announces Launch of Offering of Ordinary Shares

MDxHealth Announces Launch of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM –September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company”), a commercia...

2 months ago - GlobeNewsWire

MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript

MDxHealth SA (NASDAQ:MDXH) Q2 2024 Earnings Conference Call August 21, 2024 4:30 PM ET Company Participants Michael McGarrity - CEO Ron Kalfus - CFO Conference Call Participants Andrew Brackmann - Wi...

4 months ago - Seeking Alpha

MDxHealth Reports Q2 and Half Year 2024 Results

MDxHealth Reports Q2 and Half Year 2024 Results Year-over-year Q2 revenues increase by 32% to $22.2 million Year-over-year H1 revenues increase by 34% to 42.0 million Conference call with Q&A today at...

4 months ago - GlobeNewsWire

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21

MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21 Company to Host Conference Call with Live Q&A, August 21, 2024, at 4:30pm ET / 22:30 CET IRV...

4 months ago - GlobeNewsWire

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance

MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a commercia...

5 months ago - GlobeNewsWire

Mdxhealth Appoints Sanford J. Siegel, M.D.

Mdxhealth Appoints Sanford J. Siegel, M.D.

5 months ago - GlobeNewsWire

Mdxhealth to Present at Upcoming Investor Conferences

Mdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 (GlobeNewswire) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, t...

7 months ago - GlobeNewsWire

MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript

MDxHealth SA (NASDAQ:MDXH) Q1 2024 Results Conference Call May 1, 2024 8:30 AM ET Company Participants Michael McGarrity - CEO Ron Kalfus - CFO Conference Call Participants Andrew Brackmann - William...

7 months ago - Seeking Alpha

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 million Increasing 2024 revenue guidance to $83-85 million, previously $...

8 months ago - GlobeNewsWire

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “md...

9 months ago - GlobeNewsWire

MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript

MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Conference Call March 6, 2024 4:30 PM ET Company Participants Michael McGarrity - CEO Ron Kalfus - CFO Conference Call Participants Andrew Brackmann - Will...

10 months ago - Seeking Alpha

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results

Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42% 2023 gross margin expanded by 10.7 percentage points o...

10 months ago - GlobeNewsWire

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6

10 months ago - GlobeNewsWire

Mdxhealth Announces Resignation of Board Member

Mdxhealth Announces Resignation of Board Member IRVINE, CA, and HERSTAL, BELGIUM – February 16, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage pr...

10 months ago - GlobeNewsWire

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – January 8, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDX...

1 year ago - GlobeNewsWire

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

NEWS RELEASE – REGULATED INFORMATION DECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET              MDxHealth Announces Completion of Transition to Single Listing on Nasdaq IRVINE, CA, and HERSTAL, BELGIUM...

1 year ago - GlobeNewsWire

MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

NEWS RELEASE – REGULATED INFORMATION NOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nas...

1 year ago - GlobeNewsWire

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

NEWS RELEASE November 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35 th Annual Piper Sandler Healthcare Conference IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (...

1 year ago - GlobeNewsWire

MDxHealth SA (MXDHF) Q3 2023 Earnings Call Transcript

MDxHealth SA (OTC:MXDHF) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Michael McGarrity - Chief Executive Officer Ron Kalfus - Chief Financial Officer Conference C...

1 year ago - Seeking Alpha

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023

NEWS RELEASE – REGULATED INFORMATION 8 NOVEMBER 2023, 4:00PM EDT / 22:00 CET             MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 IRVINE, CA, and ...

1 year ago - GlobeNewsWire

MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation

NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION NOVEMBER 6, 2023, 1:00 AM ET / 7:00 CET

1 year ago - GlobeNewsWire